Bismuth, Campylobacter, and ulcer relapse.
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002169:Campylobacter Infections / Q000150:complications*; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D009942:Organometallic Compounds / Q000627:therapeutic use*; D012008:Recurrence
D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; C002791:bismuth tripotassium dicitrate